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Transdermal iontophoresis would be a promising method for the systemic delivery of water soluble 
and ionic drugs of relatively high molecular size, including peptides. The objective of the present 
study was to investigate the effect of biological variable such as guinea pig and human cadaver skin 
and other variables like drug concentration, current density on the transdermal iontophoretic transport 
of timolol maleate. The permeation profile of drug using solution and gel formulation was studied and 
compared. For better bioavailability, better patient compliance, and enhanced delivery, an iontophoretic 
drug delivery system of a timolol maleate matrix gel was formulated using Carbopol 974P. The study 
was conducted using silver–silver chloride electrodes across the guinea pig and human cadaver skin. 
Viscosity measurements and flux calculations indicated the suitability of the Carbopol 974P gel for 
transdermal iontophoretic delivery of timolol maleate. Anodal iontophoresis with silver-silver chloride 
electrode significantly increased the timolol maleate skin permeation as compared with the passive 
permeation study. The amount of timolol maleate transported during iontophoresis was significantly 
different among the different skins. However, iontophoretic gel formulations provided required flux of 
drug through human cadaver skin. 
Uniterms: Timolol maleate/transdermal iontophoretic transport. Transdermal iontophoresis/drug release. 
Drugs/release. Timolol maleate/skin permeation. Carbopol gel/ transdermal iontophoretic delivery.
A iontoforese transdérmica seria um método promissor para a liberação sistêmica de fármacos solúveis 
em água e iônicos de relativamente elevado tamanho molecular, incluindo peptídeos. O objetivo do 
presente estudo foi investigar o efeito da variável biológica, tais como cobaia e pele de cadáver humano, 
e outras variáveis como concentração do fármaco, densidade de corrente sobre o transporte transdérmico 
iontoforético de maleato de timolol. Comparou-se o perfil de permeação do fármaco usando a formulação 
de solução e de gel. Para melhor biodisponibilidade, melhor adesão do paciente e liberação aprimorada, 
formulou-se sistema de liberação iontoforética gel de maleato de timolol usando Carbopol 974P. O estudo 
foi conduzido usando eletrodos de prata-cloreto de prata na cobaia e na pele de cadáver humano. Medidas 
de viscosidade e de fluxo indicaram a adequação do gel Carbopol 974 P para liberação iontoforética 
transdérmica do maleato de timolol. A iontoforese anódica com eletrodo de prata-cloreto de prata aumentou 
significativamente a permeação dérmica do maleato de timolol, comparativamente à permeação passiva. 
A quantidade de maleato de timolol transportado durante a iontoforese foi significativamente diferente 
entre as diferentes peles . No entanto, as formulações iontoforéticas de gel forneceram o fluxo necessário 
do fármaco através da pele de cadáver humano.
Unitermos: Maleato de timolol/transporte transdérmico iontoforético. Iontoforese transdérmica/liberação 
de fármacos. Fármacos/liberação. Maleato de timolol/permeação dérmica. Carbopol gel/liberação 
iontoforética transdérmica.
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INTRODUCTION
Iontophoresis is defined as the facilitated move-
ment of ions of soluble salts across a membrane under an 
externally applied potential difference. Iontophoresis is a 
non-invasive drug delivery system with no trauma, risk 
of infection or damage to the wound and is therefore an 
important alternative to injection therapy (Singh, Howard, 
1996; Banga, Bose, Ghosh, 1999). Iontophoresis allows 
controlled programmed delivery of variety of compounds. 
Charged drugs as well as other ions are carried across the 
skin as a component of induced ion flow. Iontophoresis 
effectively delivers a large variety of compounds across 
the skin (Heit, Riviere, 1997; Fitzpatrick, Corish, 2006; 
Kanikkannan, Singh, Ramarao, 2000). Several investiga-
tors identified that, many formulation factors like drug 
concentration, pH, ion composition and current density 
may influence the iontophoretic transport (Green, 1996; 
Saraf, Dixit, 1996).
Transdermal permeation of drugs across the skin of 
animals like rat, rabbit and mouse is significantly higher 
than human skin. Most investigators prefer excised human 
skin for in vitro transdermal studies as it is more relevant; 
but its availability on regular basis limits its applications. 
A variety of excised animal skin like rat, rabbit and guinea 
pig is suitable as alternative to human skin owing to their 
availability (Kanikkannan, Singh, Singh, 2001; Pathan, 
Mallikarjun, 2008).
Timolol maleate is non-selective beta-adrenergic 
blocking agent without membrane stabilizing or intrinsic 
sympathomimetic activities. It is used in the management 
of hypertension, angina pectoris, myocardial infarction 
and glaucoma. Timolol maleate, being antihypertensive, 
is used to control hypertension in the elderly with doses of 
10 to 40 mg administered 2 times a day. It undergoes exten-
sive presystemic metabolism and its elimination half life 
is 4h, ionized at physiological pH, oral bioavailability is 
only 60-70% and therefore, it is an excellent candidate for 
transdermal iontophoresis. Timolol maleate has biological 
half life of 2.5 to 5 hours. For oral formulation with short 
biological half life and high body clearance rate, frequent 
dosing is required to elicit and maintain pharmacological 
effect. To surpass the presystemic metabolism and increase 
the bioavailability of timolol maleate, iontophoretic trans-
dermal drug delivery, can be a suitable approach (Sweet-
man, 2007; Flory, 2005; Dimitrios, Joke, 2004). Some 
investigators studied the iontophoresis of timolol maleate 
and reported increased transport and control delivery of 
the drug.
The present study was aimed to assess the feasibility 
of electrically assisted delivery of timolol solution and gel 
formulation through guinea pig skin and to compare it with 
excised human skin. Furthermore, the transdermal timolol 
delivery from a Carbopol 974P matrix gel was investi-
gated. The effect of drug concentration and current density 
on the timolol maleate permeation was also investigated.
MATERIAL AND METHODS
Timolol maleate (Purity 99.6%) was obtained as a 
gift sample from FDC Ltd., Aurangabad, India. Carbopol 
974P was purchased from Noveon, India. Potassium 
dihydrogen phosphate and sodium hydroxide were pur-
chased from Merck, India. Silver chloride was purchased 
from Research fine lab, Mumbai. All other chemicals and 
reagents were of analytical grade. Silver wire (1 mm diam-
eter, 99.9% pure) was purchased from local supplier. All 
solutions were prepared from Millipore water (resistance 
18 MΩ).
The amount of timolol maleate in the samples was 
quantified using UV spectrophotometer (SHIMADZU, 
1700-PC, Japan).
Preparation of skin samples
Freshly excised full thickness (approximately 300-
400 µm), abdominal skin of guinea pig and human cadaver 
was used. In all experiments, hair was removed using hair 
remover clipper 24 h before experiment taking care not 
to damage the stratum corneum. The human cadaver skin 
was prepared within 24 h of its removal from the body. 
The skin was stored at very low temperature (-20 oC) in 
sterile cotton gauze soaked in normal saline, wrapped by 
aluminum foil and then thawed just before use. Animal 
experiments were conducted in full compliance with 
institutional animal ethics committee (IAEC, CPCSEA, 
Government College of Pharmacy, Aurangabad, India).
In vitro iontophoretic transport studies
The excised skin (guinea pig, human cadaver) was 
mounted between donor and receptor chamber of the 
modified Keshary Chien diffusion cell (surface area 3.88 
cm2) with epidermal side facing the donor fluid. The do-
nor chamber was filled with drug solution and phosphate 
buffer pH 7.4 was placed in the receptor chamber. The 
diffusion medium in the receptor chamber was stirred 
using star-headed magnetic bead bar (size 10 × 10 mm) 
(Himedia) rotating at constant speed of 600 rpm by mo-
torless magnetic mega stirrer (Whirlmatic-Mega, Spec-
tralab) and the temperature in the bulk of the solution was 
maintained at a constant level of 37 ± 1oC using constant 
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temperature water circulating bath (Deep Engineering), 
which circulates thermostated water through the water 
jacket surrounding the receptor compartment. In all ex-
periments, the drug solution was left in the donor chamber 
till the end of experiment (7 h). Unless stated otherwise 
current density was 0.5 mA/cm2. Silver wire was used as 
anode and silver/silver chloride as the cathode. Timolol 
maleate is positively charged (+1) at pH = 7.4 and anodal 
iontophoresis was used. Passive diffusion experiments 
were carried out without application of current to compare 
with iontophoretic study. Samples (1 mL) were withdrawn 
from the receptor chamber at predetermined time intervals 
and an equal volume of fresh diffusion medium was added 
to the receptor medium. The withdrawn samples were 
centrifuged (Spinwin, Tarsons) for 10 min. at 1000 rpm 
and analyzed by UV spectrophotometer (SHIMADZU 
1700-PC) at 294.50 nm. All experiments were carried out 
in triplicate. 
Effect of drug concentration on passive and 
iontophoretic permeation through guinea pig skin
The experimental set up for the in vitro permeation 
study was similar to as described previously in the above 
section. In this study, 3 ml of timolol solution in phosphate 
buffer pH 7.4 at different concentrations (10, 20, 30 and 40 
mg/ml) were added to donor compartment. Iontophoretic 
application was comprised of direct continuous current of 
0.5 mA/cm2 using silver-silver chloride electrode. Amount 
of timolol maleate permeated was estimated by using UV 
spectrophotometer (SHIMADZU 1700-PC) at 294.50 nm. 
Concentration of drug to be taken for further study was 
optimized based on the results.
Effect of current density on permeation through 
guinea pig skin
The influence of current density on transport of 
Timolol maleate across guinea pig skin was investigated 
at the same anodal conditions, as described for transport 
studies. The current density was varied from 0.2 to 0.4 
and to 0.5 mA/cm2.
In vitro permeation study through human cadaver 
skin
The experimental set up for the in vitro perme-
ation study was similar to as described previously in the 
above section. Donor compartment comprised of 3 mL of 
30 mg/mL timolol maleate solution and current density 
of 0.5 mA/cm2 was applied for iontophoretic application. 
Amount of timolol maleate permeated was estimated by 
using UV spectrophotometer.
Preparation of Carbopol 974P matrix gel
Previously weighed quantity of Carbopol 974P at 
concentration (1 and 1.5% w/w) was slowly dispersed into 
sufficient quantity of water, with continuous mixing until 
Carbopol 974P swelled completely. During gel prepara-
tion, the solution was agitated slowly to avoid introduc-
tion of air bubbles. A 30 mg/g of timolol maleate was 
incorporated by mixing with sufficient quantity of water. 
The effect of neutralizing agent to the above solution was 
studied by adding triethanolamine in a concentration of 
1.75 and 2% w/w respectively and agitated for 30 min to 
obtain a gel (Table I).
The resultant gels were subjected for clarity, con-
sistency, drug content (by UV spectrophotometer) and 
viscosity (Brookfield R/S plus Rheometer and spindle 
no.C25-2) determination. All gels were tested for in vitro 
permeation through guinea pig skin.
In vitro permeation of timolol maleate from 
Carbopol 974P matrix gel through guinea pig 
skin and human cadaver skin via passive and 
iontophoretic process
The effect of matrix gel on timolol maleate perme-
ation was studied by subjecting all the gel formulations 
(F1, F2, F3 and F4) for passive and iontophoretic perme-
ation through guinea pig skin and human cadaver skin. 
Gel formulation (3 g) was applied to epidermal side of 
membrane. The optimized gel formulation was subjected 
to passive and iontophoretic permeation study through hu-
TABLE I - Composition of Carbopol gels
Formulation code Carbopol 974P (%w/w) Timolol maleate (mg/g) Triethanolamine (%w/w) Water (g)
F1 1 30 1.75 10
F2 1 30 2 10
F3 1.5 30 1.75 10
F4 1.5 30 2 10
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man cadaver skin. Amount of timolol maleate permeated 
was estimated by using UV spectrophotometer. 
Data analysis
The real steady-state situation was not observed 
clearly during permeation studies. Therefore cumulative 
amount of timolol maleate permeated per unit surface area 
of skin was plotted against time and the slope of the linear 
portion of the plot was estimated as steady-state flux (Jul-
raht, Keith, James, 1995). The enhancement ratio (Er) for 
the flux was calculated by using Equation Er = Iontophoretic 
Flux/Passive Flux and Permeability coefficient (Kp) was 
calculated using equation Kp = Flux/ Initial amount of drug 
in donor compartement (Oh H, Oh Y, Kim, 2001; Kotwal, 
Bhise, Thube, 2007). The permeation parameters obtained 
were compared by one-way analysis of variance (ANOVA). 
Tukey-Kramer test and Dunnett test were performed for 
multiple comparisons amongst the different formulations, 
respectively. The probability level, p < 0.001, was consid-
ered statistically significant and probability level P > 0.05, 
was considered statistically insignificant.
RESULTS AND DISCUSSION
Effect of drug concentration
Effect of drug concentration (10, 20, 30 mg/mL) on 
the passive and iontophoretic permeation from vehicle 
formulations through guinea pig skin was studied and 
permeation profiles are as shown in Figure 1.
Statistically significant differences were observed 
in flux (P<0.001) with 20 mg/mL, 30 mg/mL passive and 
iontophoretic application. Highest flux of 20.832 ± 2.08 
and 456.755 ± 38.67 μg/cm2/h was obtained from 30 mg/
mL solution when evaluated for passive and iontophoretic 
application respectively as shown in Table II. As there was 
linear increase in the flux with passive and iontophoretic 
process, 30 mg/mL drug concentration was selected as 
optimized drug concentration for the further studies. This 
may be attributed to the fact that as concentration gradient 
increase across the skin, flux also increases in accordance 
with accepted theory. (Kalia et al., 2004).
Effect of current density
The variation in the current density has marked 
influence on permeation of drugs through membrane. In 
general 0.5 mA/cm2 is often stated to be the maximum 
iontophoretic current which should be used on human be-
ing (Banga, 1998; Lawler, Devis, Giiffith, 1960; Kalia et 
al., 2004). The extent of charged molecules, which may 
penetrate through the skin, are proportional to the density 
of current and the duration of treatment for a transdermal 
iontophoretic delivery.
Effect of current density (0.2, 0.4, 0.5 mA/cm2) on 
the permeation from vehicle formulations through guinea 
pig skin was studied and permeation profiles are presented 
in Table III. 
Statistically significant differences (P<0.001) were 
observed between the flux of drug solution when evaluated 
for different current densities (0.2, 0.4, 0.5 mA/cm2) and 
compared with passive application respectively, as shown 
in Figure 2. The maximum flux of 456.755 ±38.67 μg/cm2/h 
TABLE II - Effect of drug concentration
Drug Concentration (mg/mL)
10 10 20 20 30 30
Permeation 
parameter
Passive Iontophoresis Passive Iontophoresis Passive Iontophoresis
Jss (μg/cm2/h) 7.851±1.10 103.785±3.92a 16.813±0.58b 247.697±4.51a 20.832±2.08b 456.755±38.67a
Kp 0.000238±0.0001 0.0033±0.0014a 0.00027±0.00010b 0.0040±0.0009a 0.000278±0.000067a 0.0047±0.0012b
Jss= Steady state flux, Kp= Permeability coefficient; a = statistically significant difference from passive study (P<0.001), b = 
statistically not significant difference from passive study (P>0.05)
FIGURE 1 - Comparison of effect of drug concentration.
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TABLE III - Effect of current density
Current Density (mA/cm2)
Permeation parameter
0.2 0.4 0.5
Passive Iontophoresis Iontophoresis Iontophoresis
Q7 (μg/cm2) 295.97±24.41 1467.71±32.11 a 2424.51±44.50 a 5143.21 ±68.01a
Jss (μg/cm2/hr) 20.832±2.08 203.391±14.35 a 328.759±16.35 a 456.755 ±38.67 a
Kp 0.000278±0.000067 0.00237±0.0012b 0.00378±0.0026 a 0.0047±0.0012b
ER 1 9.763 15.781 21.925
Q7 = Cumulative amount permeated in 7 h, Jss= Steady state flux, Kp= Permeability coefficient, ER= Enhancement ratio. a = 
statistically significant difference from passive study (P<0.001), b = statistically not significant difference from passive study 
(P>0.05)
at current density of 0.5mA/cm2 was obtained and found 
to be significantly higher than flux of passive and other 
current densities (0.2, 0.4 mA/cm2). Hence 0.5 mA/cm2 
current density has been selected for further studies (Pan-
zade et al., 2012).
Ex vivo permeation study through human cadaver skin
It has been reported that various factors which 
affects the permeation of drug includes, drug concentra-
tion, current density, temperature, and type of membrane. 
It has also been reported that human skin is primary in 
vitro model for skin permeability studies and gives more 
reliable data than other types of membranes. Therefore a 
comparative permeation study was carried out for timolol 
maleate through guinea pig skin and human cadaver skin 
via passive and iontophoresis process.
Statistically significant difference (P<0.001) in flux 
was observed between the guinea pig skin and human 
cadaver skin via passive and iontophoretic application.
FIGURE 2 – Effect of current density.
The flux of 30 mg/mL solution formulation through 
excised guinea pig skin and human cadaver skin was found 
to be 456.755±38.67 µg/cm2/h and 59.974±0.755 µg/cm2/h 
respectively via iontophoretic application with enhance-
ment ratio of 21.925 and 9.735 respectively at 0.5 mA/cm2 
as shown in Figure 3.
In vitro permeation of timolol maleate from 
Carbopol 974P matrix gel
Gels are clinically acceptable delivery systems for 
iontophoresis in terms of stability and ease of handling 
and refilling of iontophoretic patches (Valenta, Auner, 
2004; Nair et al., 2012). The aim of this study was to 
evaluate in vitro permeation of timolol maleate from 
prepared gel formulations viz. F1, F2, F3 and F4 through 
guinea pig skin via passive and iontophoretic process. 
The flux obtained from the different gel formulations 
via passive and iontophoretic process are summarized 
in Table IV.
The study demonstrates that, there was linear de-
crease in flux via passive and iontophoretic application 
FIGURE 3 - Comparison of drug solution through guinea pig 
and human skin.
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through guinea pig skin with increase in the viscosity of 
the gel formulations as seen in Figure 4.
The pH and relative viscosities of Carbopol gels 
were found to increase with the increase in the concentra-
tions of conventional neutralizing agent triethanolamine 
(Zhang, Schung, 1996). Increasing the amount of the poly-
mer in the formulations decreased the apparent flux from 
the formulations but increased the time it took for the drug 
to leave the formulation and to diffuse into the receptor 
medium (Edsman, Carlfors, Harju, 1996; Bounoure et al., 
2008). Although maximum flux was obtained for F1 for-
mulation, F2 formulation was selected for further studies 
because of viscosity and other evaluation parameters of F2 
formulation. The optimized formulation F2 showed flux 
value of 9.60±0.98 and 96.00± 0.76 µg/cm2/h for passive 
and iontophoretic application respectively at viscosity of 
0.6824±0.0108 Pa/s. Thus, the concentration of Carbopol 
974P was optimized to produce a gel with enough viscosity 
to hold the formulation in the electrode cavity when the 
electrode is applied to the skin.
The optimized formulation was subjected fur-
ther to permeation study by using human cadaver skin. 
Permeation of drug greatly varies with skin because of 
wide differences in physical characteristic of skin such 
as appendages per unit area, thickness and structural 
changes between human and guinea pig skin. Statistically 
significant difference (P<0.001) in flux was observed 
between the guinea pig skin and human cadaver skin 
via passive and iontophoretic application as shown in 
Figure 5. The flux for formulation F2 through excised 
guinea pig skin and human cadaver skin was found to be; 
96.00± 0.76 µg/cm2/h and 23.27±4.239 µg/cm2/h respec-
tively via iontophoretic application with enhancement 
ratio of 10 and 9 respectively.
Skin appendages which include sweat glands and 
hair follicles are considered to be major pathways of drug 
transport during iontophoresis. During iontophoresis, the 
greatest concentration of ionized species is expected to 
move into some regions of the skin where there is dam-
age, or along the sweat glands and hair follicles, as the 
diffusional resistance of the skin to permeation is lowest 
in these regions. Thus, pore pathway is generally assumed 
for iontophoretic delivery. The significant increase in flux 
was observed through guinea pig skin, as compared to 
human cadaver skin. This may be due to the difference in 
TABLE IV - Evaluation and permeation study of gels via passive and iontophoretic process
Formulation 
Code
Dilution pH Drug Content 
(mg/g)
Viscosity 
(Pa/Sec)
Clarity Consistency Passive 
(µg/cm2/h)
Iontophoretic 
(µg/cm2/h)
F1 7.1±0.41 28.81 0.5485±0.016 + + 17.086±0.98 108.81± 16
F2 7.6 ±0.25 29.49 0.6824±0.0108 + + + + + + 9.60±0.98 96.00± 0.76
F3 6.51±0.55 29.36 23.74±0.305 + + + + 6.99±0.83 84.22± 1.53
F4 6.83±0.16 28.26 39.74±0.48 + + 3.72±0.54 65.97± 1.13
FIGURE 4 - Comparison of gel formulations through guinea 
pig skin.
FIGURE 5- Comparison of optimized (F2) carbopol matrix gel 
across different skin.
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TABLE V - Comparative permeation of drug solution and gel through different skin
Permeation 
parameters
Permeation of drug solution and F2 gel through skin of different species
Guinea pig skin Human cadaver skin Guinea pig skin Human cadaver skin
P-Sol P-Gel P-Sol P-Gel I-Sol I-Gel I-Sol I-Gel
Jss μg/cm2/h 20.832±2.08 9.60±0.98 a 6.160±0.875 a 2.36±
0.875 a
456.755±
38.67 a
96.00±0.76 a 59.974±
0.755 a
23.27±
4.239 a
Kp 0.000278±
0.000067
0.000098±
0.00001 a
0.000068±
0.000021b
0.000026±
0.0000081a
0.0047±
0.0012 a
0.00107±
0.00015 a
0.000663±
0.00038 a
0.0002±
0.00006 a
ER 1 1 1 1 21.925 10 9.735 9
Jss= Steady state flux, Kp= Permeability coefficient, ER= Enhancement ratio, P-sol = passive solution, P-gel = passive gel, I-gel= 
iontophoresis gel, I-sol= iontophoresis solution. a = statistically significant difference from passive study (P<0.001), b = statistically 
not significant difference from passive study (P>0.05)
hair follicles of human cadaver skin (6/inch2) and Guinea 
pig skin (5000/inch2). Variation in the thickness of skin 
may also be responsible for affecting the permeation of 
drug, the order of thickness of skin is as follows: Human 
cadaver skin > Guinea pig skin.
Comparison of solution and gel formulation
The permeation profile of timolol maleate through 
guinea pig and human cadaver skin via passive and ion-
tophoretic application from solution and optimized F2 
Carbopol 974P matrix gel formulation was studied and is 
presented in Table V.
Statistically significant differences in flux (P<0.001) 
have been observed between the solution and gel for-
mulations when evaluated through guinea pig skin and 
human cadaver skin via iontophoretic application. The 
obtained flux through guinea pig skin for iontopho-
retic solution formulation was higher and found to be 
456.755±38.67 μg/cm2/h compared to iontophoretic gel 
formulation 96.00±0.76 µg/cm2/h.
The obtained flux through human cadaver skin for 
iontophoretic solution formulation was higher and found 
to be 59.974±0.755 μg/cm2/hcompared to iontopho-
retic gel formulation 23.27±4.239 µg/cm2/hr, as shown in 
Figure 6.
Statistically significant differences in flux (P<0.001) 
have been observed between the solution and gel formula-
tions when evaluated through guinea pig and human cadaver 
skin via passive application. The obtained flux through guin-
ea pig skin for passive solution formulation was higher and 
found to be 20.832±2.08 µg/cm2/h compared to passive gel 
formulation 9.60±0.98 μg/cm2/h. The obtained flux through 
human cadaver skin for passive solution formulation was 
higher and found to be 6.160±0.631 μg/cm2/h compared to 
passive gel formulation 2.36±0.875 µg/cm2/h.
FIGURE 6 - Permeation of drug solution and optimized F2 gel 
through different skin.
CONCLUSION
The results of present experiment showed that 
timolol maleate transdermal flux increases essentially 
linearly as a function of its concentration and applied 
current density through guinea pig and human cadaver 
skin. Hence, timolol maleate may be excellent candidate 
for iontophoresis. The gel formulations showed signifi-
cantly higher flux through guinea pig skin than human 
cadaver skin. However, iontophoretic application pro-
vided required flux when optimized gel formulation was 
studied over human cadaver skin. The present study dem-
onstrated the feasibility of timolol maleate transdermal 
transport through Carbopol 974P gel by iontophoresis. 
Further more extensive in vivo studies are required to 
support in vitro results and to develop in vitro–in vivo 
correlations.
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